Aleksandar Videnovic, MD
Enriched profileProfessor of Neurology, Harvard Medical School; Chief, Division of Sleep Neurology, Mass General Brigham; Director, MGH Program on Sleep, Circadian Biology, and Neurodegeneration · Harvard Medical School
Aleksandar Videnovic is Professor of Neurology, Harvard Medical School; Chief, Division of Sleep Neurology, Mass General Brigham; Director, MGH Program on Sleep, Circadian Biology, and Neurodegeneration at Harvard Medical School. OpenAlex indexes 186 publications with 9,657 citations (h-index 47); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Aleksandar Videnovic, M.D., is Professor of Neurology, Harvard Medical School. The public record shows 186 publications with 9,657 citations (h-index 47), centered on Parkinson's Disease Mechanisms and Treatments, Sleep and related disorders, Dementia and Cognitive Impairment Research. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 2 companies, 7 NIH-funded awards (2013–2026).
- Most recent indexed publication: 2026 · Neurology
- Top research focus: Parkinson's Disease Mechanisms and Treatments
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 14 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 96.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Sponsor: Michael J. Fox Foundation for Parkinson's Research
- Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease
Sponsor: Massachusetts General Hospital
Industry payments
Updated 16 Oct 2026
2 companies reported payments to CMS in program years 2021–2023. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year20234 payments
- Alexion Pharmaceuticals, Inc.Program year20227 payments$10,313openpaymentsdata.cms.gov ↗
- Neurocrine Biosciences, Inc.Program year20221 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
97.5%Aromatic Amino Acid Decarboxylation Inhibitor39.6%Carbidopa-Levodopa84%Carbidopa-Levodopa Er12%Rytary4%Part D<11 patientsBenzodiazepine11%Clonazepam100%Part D≥18 patients+ 8 more classes in this area
Cardiovascular
2.5%alpha-Adrenergic Agonist2.5%Midodrine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
7 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC)
Massachusetts General Hospital
FY2026$2,770,869U01NS077179 - A Consortium for Gut-Brain Communication in Parkinson's Disease
Columbia University Health Sciences
FY2026$757,440U01DK140933
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Accelerated Progression of Gait Impairment in Parkinson's Disease and REM Sleep Without Atonia.
Annals of clinical and translational neurology
Article2026 - ENLITE PD: A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson's Disease.
Movement disorders
Clinical Trial2025 - IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder: A Multicenter Study.
Neurology(R) neuroimmunology & neuroinflammation
Article2024
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Idiopathic REM sleep behaviour disorder and neurodegeneration — an updateReview540 citations2017
- 04Circadian Melatonin Rhythm and Excessive Daytime Sleepiness in Parkinson DiseaseArticle387 citations2014
- 05'The clocks that time us'—circadian rhythms in neurodegenerative disordersReview373 citations2014
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/aleksandar-videnovic-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
sleep.hms.harvard.edu/faculty-staff/aleksandar-videnovic
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sleep.hms.harvard.edu ↗ - Other
worldmedicalinnovation.org/speaker/aleksandar-videnovic-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →worldmedicalinnovation.org ↗ - Other
massgeneral.org/neurology/doctors/19418/aleksandar-videnovic
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - Other
neuro-central.com/podcasts/nctalks-aleksandar-videnovic-career-clinical-trials-involve
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neuro-central.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →michaeljfox.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →michaeljfox.org ↗
Editorial & leadership roles
journal and society appointments- Co-Chair
Steering Committee for Gut-Brain Communication in Parkinson's Disease Consortium
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sleep.hms.harvard.edu ↗ - Executive Steering Committee Member
Parkinson's Progression Markers Initiative
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sleep.hms.harvard.edu ↗ - Director
REM Sleep Behavior Disorder Clinical/Research Program, MGH
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →michaeljfox.org ↗ - Director
Recruitment, Education, and Outreach Core, North American Prodromal Synucleinopathy RBD Consortium
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sleep.hms.harvard.edu ↗
Secondary affiliations
appointments beyond the home institution- Mass General Brigham
Chief of Division of Sleep Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →michaeljfox.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida